One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.
CVS recently announced that it’s pulling the heartburn medication Zantac from its shelves, alongside its store-brand generic. One of the companies that makes generic ranitidine, including the store ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback